GHRP-6 Reference
Educational, not medical advice reference for GHRP-6: GH Release; regulatory status, evidence posture, source review, and schedule notes. Also k…
Plain English
- What it is
- GHRP-6 is a lab-made peptide, which is a short chain of amino acids. It mimics ghrelin, the body's hunger hormone, by switching on the same receptor, which tells the brain to release a pulse of natural growth hormone. It is sold only as a research chemical and is not an FDA-approved medicine.
- What people use it for
- In the peptide community, people use it to push the body to put out more of its own growth hormone. Its standout feature is a strong, reliable boost in appetite, so it is popular with people who are trying to eat more and build muscle.
- What the science shows
- Older short-term studies in healthy men showed that it does trigger growth hormone release, and that it works together with another hormone called GHRH to release even more. Animal studies show it strongly switches on the brain's appetite centers. The human research is dated and limited, with little long-term safety or outcome data, and nothing like the modern testing done for newer peptides.
- The catch
- It is not an approved drug, and the FDA has flagged GHRP-6 as a bulk substance that may pose safety risks when used in pharmacy compounding. It is also banned in sport at all times under World Anti-Doping Agency rules. The appetite effect can be intense, and the long-term effects in people are not well understood.
Reference summary
Early human GH-response work in healthy volunteers documented GH secretion following GHRP-6 administration. Evidence is older and primarily short-term; long-term clinical outcome data are limited, and no modern PK/PD or outcome program comparable to ipamorelin or CJC-1295 exists.
Regulatory and posture
- Categories
- GH Release
- Aliases
- SKF-110679, Growth hormone releasing hexapeptide
- Evidence posture
- translational - Evidence is limited to older, short-term human GH-response studies without modern PK/PD or outcome follow-up. Strong ghrelin-class appetite stimulation is consistently reported.
- Regulatory status
- No FDA-approved GHRP-6 drug label. FDA lists GHRP-6 among bulk drug substances with safety-risk concerns for compounding.
- Content review status
- research reference
Selected public sources
- FDA bulk drug substances with significant safety risks
- PubMed: Bowers 1990 GHRP (GHRP-6) stimulates GH release and is synergistic with GHRH in normal men (J Clin Endocrinol Metab)
Related tools
- Peptide reconstitution calculator - Convert vial mass and BAC water volume into mcg/ml.
- BAC water calculator - Solve BAC water volume for a target concentration.
- Multi-dose vial calculator - Estimate doses per vial and a projected vial-empty date.
- Reconstituted-vial storage window calculator - Estimate a generic usable-window date and days remaining.
- Peptide half-life calculator - Estimate single-dose decay from cited half-life constants.
- Injection-site rotation overview - Public overview of the Pro site-rotation planner.
For research and educational purposes only. Not medical advice.